ESR1 and breast cancer: Triple negative breast cancer (TNBC) accounts for approximately 10%–15% of all breast cancers and is characterized by a lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)3.